PBYA Financials Monday, July 14, 2014 10:57:37 PM
Post# of 89
Panther Biotechnology, Inc.
Period Ending May 31, 2013 May 31, 2012
Total Revenue 73 -
Cost of Revenue 13 -
Gross Profit 60 -
Operating Expenses
Research and Development - -
Sales, General and Admin. 66 -
Non-Recurring Items - -
Other 1 -
Operating Income (7) -
Income From Continuing Operations
Add'l Income/Expense Items - -
Earnings Before Interest and Tax (7) -
Interest Expense - -
Earnings Before Tax (7) -
Income Tax - -
Minority Interest - -
Equity Earnings Unconsolidated Subsidiary - -
Net Income Cont. Operations (7) -
Non Recurring Events
Discontinued Operations - -
Extraordinary Items - -
Effect of Accounting Changes - -
Other Items - -
Net Income (7) -
Preferred Stock and Other Adjustments - -
Net Income Applicable to Common Shareholders (7) -